Association between thyrotropin levels and insulin sensitivity in euthyroid obese adolescents.

BACKGROUND Thyrotropin (TSH) levels display a positive association with body mass index (BMI), and the prevalence of isolated hyperthyrotropinemia is higher in obese adolescents compared to their normal weight controls. However, the metabolic significance of the higher TSH in obese adolescents is less clear. The objective of this study was to determine the relationship between TSH concentrations and insulin sensitivity, lipids, and adipokines in euthyroid, non-diabetic, obese adolescents. METHODS Thirty-six euthyroid, non-diabetic, obese adolescents between the ages of 12 and 18 years underwent a 75 g oral glucose tolerance test. Insulin sensitivity (Si) and pancreatic β-cell function as assessed by disposition index (DI) were measured using the oral glucose minimal model approach. Cholesterol (total, low-density lipoprotein [LDL-C], and high-density lipoprotein [HDL-C]), triglycerides (TG), interleukin-6 (IL-6), total and high molecular weight (HMW) adiponectin, and retinol binding protein-4 (RBP4) were also determined. Associations between measures of thyroid function and Si, DI, lipids, and adipokines were computed using Pearson's correlation coefficient and multiple regression analysis. RESULTS The mean age of the subjects was 14.3±1.88 years, and the mean BMI was 32.5±4.65 kg/m2; 97% were non-Hispanic white and 47% were male. The mean TSH was 2.7±1.2 mIU/L. Increasing serum TSH was correlated with decreasing Si (log Si) in the entire cohort (p=0.03), but this relationship persisted only in males (p=0.02). The correlation between TSH and Si in males remained significant after adjusting for BMI (p=0.02). There was no correlation between TSH and pancreatic β-cell function as assessed by DI (p=0.48). TSH correlated positively with LDL-C (p=0.04) and IL-6 (p=0.03), but these associations vanished or weakened after adjusting for BMI (LDL-C p-value=0.44; IL-6 p-value=0.07). CONCLUSIONS This study suggests a sex-specific association between TSH and insulin sensitivity in euthyroid, non-diabetic, obese adolescent males. Prospective studies are warranted to explore further this sexual dimorphism in the relationship between thyroid function and insulin sensitivity and to determine if obese adolescents with insulin resistance receiving thyroid supplements for hypothyroidism would benefit from targeting TSH levels in the lower half of normal range.

[1]  A. Abacı,et al.  Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters , 2014, Journal of Endocrinological Investigation.

[2]  Claudio Cobelli,et al.  The Oral Minimal Model Method , 2014, Diabetes.

[3]  M. Serdar,et al.  Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance. , 2013, Archives of medical research.

[4]  T. Reinehr,et al.  TSH and free triiodothyronine concentrations are associated with weight loss in a lifestyle intervention and weight regain afterwards in obese children. , 2013, European journal of endocrinology.

[5]  A. Chawla,et al.  Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis , 2013, Science.

[6]  M. Manco,et al.  Thyroid Function Tests in Obese Prepubertal Children: Correlations with Insulin Sensitivity and Body Fat Distribution , 2012, Hormone Research in Paediatrics.

[7]  C. Cobelli,et al.  A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations , 2012, Clinical endocrinology.

[8]  T. Reinehr Thyroid function in the nutritionally obese child and adolescent , 2011, Current opinion in pediatrics.

[9]  M. Zimmermann,et al.  During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat. , 2010, The Journal of clinical endocrinology and metabolism.

[10]  A. Weaver,et al.  Relationships between thyroid function and lipid status or insulin resistance in a pediatric population. , 2010, Thyroid : official journal of the American Thyroid Association.

[11]  S. Pilia,et al.  Thyroid Function in Obese Children and Adolescents , 2010, Hormone Research in Paediatrics.

[12]  A. Vidal-Puig,et al.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. , 2010, Biochimica et biophysica acta.

[13]  T. Economopoulos,et al.  Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. , 2010, European journal of endocrinology.

[14]  J. Fernández-Real,et al.  Adipocytokines and Insulin Resistance , 2009, Diabetes Care.

[15]  A. Falus,et al.  The major inflammatory mediator interleukin-6 and obesity , 2009, Inflammation Research.

[16]  H. Price,et al.  The upper limit of the reference range for thyroid-stimulating hormone should not be confused with a cut-off to define subclinical hypothyroidism , 2009, Annals of clinical biochemistry.

[17]  S. Shalitin,et al.  Prevalence of Thyroid Dysfunction in Obese Children and Adolescents before and after Weight Reduction and Its Relation to Other Metabolic Parameters , 2009, Hormone Research in Paediatrics.

[18]  E. Esteve,et al.  The possible role of lipocalin-2, retinol binding protein-4, and adiponectin , 2009 .

[19]  K. Park,et al.  Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance. , 2008, The Journal of clinical endocrinology and metabolism.

[20]  C. Hsieh,et al.  Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function. , 2008, Endocrine journal.

[21]  V. Funanage,et al.  Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. , 2007, The Journal of clinical endocrinology and metabolism.

[22]  B. Wolffenbuttel,et al.  Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. , 2007, The Journal of clinical endocrinology and metabolism.

[23]  N. Bukan,et al.  Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism , 2006, Clinical endocrinology.

[24]  J. Fernández-Real,et al.  Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. , 2006, The Journal of clinical endocrinology and metabolism.

[25]  T. Reinehr,et al.  Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. , 2006, The Journal of clinical endocrinology and metabolism.

[26]  U. Smith,et al.  Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. , 2006, The New England journal of medicine.

[27]  J. Sundsfjord,et al.  Serum TSH is positively associated with BMI , 2006, International Journal of Obesity.

[28]  Claudio Cobelli,et al.  Insulin sensitivity by oral glucose minimal models: validation against clamp. , 2005, American journal of physiology. Endocrinology and metabolism.

[29]  T. Jørgensen,et al.  Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. , 2005, The Journal of clinical endocrinology and metabolism.

[30]  F. Leonetti,et al.  Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women , 2005, Clinical endocrinology.

[31]  Sonia Caprio,et al.  Obesity and the metabolic syndrome in children and adolescents. , 2004, The New England journal of medicine.

[32]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[33]  Claudio Cobelli,et al.  Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. , 2004, American journal of physiology. Endocrinology and metabolism.

[34]  G. Steil,et al.  Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test. , 2004, Diabetes.

[35]  A. Pinchera,et al.  Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions , 2004, Journal of endocrinological investigation.

[36]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[37]  H. Gharib,et al.  Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[38]  P. Iglesias,et al.  Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function , 2003, Clinical endocrinology.

[39]  W. Dietz,et al.  Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of pediatrics & adolescent medicine.

[40]  B. Kahn,et al.  Glucose transporters and pathophysiological states , 2003 .

[41]  Claudio Cobelli,et al.  The oral glucose minimal model: Estimation of insulin sensitivity from a meal test , 2002, IEEE Transactions on Biomedical Engineering.

[42]  Shumei S. Guo,et al.  2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.

[43]  H. Vidal,et al.  Regulation of human adipocyte gene expression by thyroid hormone. , 2002, The Journal of clinical endocrinology and metabolism.

[44]  J. T. ter Maaten,et al.  The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. , 2001, The Journal of clinical endocrinology and metabolism.

[45]  B. Kahn,et al.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.

[46]  V. Abbassi,et al.  Growth and normal puberty. , 1998, Pediatrics.

[47]  B. Kahn Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. , 1992, The Journal of clinical investigation.

[48]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[49]  J M Tanner,et al.  Variations in the Pattern of Pubertal Changes in Boys , 1970, Archives of disease in childhood.

[50]  J M Tanner,et al.  Variations in pattern of pubertal changes in girls. , 1969, Archives of disease in childhood.